Vl. Miller et al., Fiscal impact of a potential legislative ban on second trimester elective terminations for prenatally diagnosed abnormalities, AM J MED G, 91(5), 2000, pp. 359-362
This study was designed to determine the fiscal impact of a theoretical leg
islative ban on elective terminations for prenatally diagnosed abnormalitie
s at Hutzel Hospital/Wayne State University. A fiscal comparison was comple
ted for patients who had second trimester elective terminations for prenata
lly diagnosed abnormalities versus not allowing the procedure. An eight-yea
r database of genetics cases and hospital and physician cost estimates for
performing elective terminations for prenatally diagnosed abnormalities, an
d published reports of the average lifetime costs per selected birth defect
s, were used to calculate the net cost. The estimated lifetime cost for an
average cohort year of a legislative ban on elective terminations for prena
tally diagnosed abnormalities was found to be at least $8.5 million for pat
ients treated at Hutzel Hospital. Extrapolated, a similar ban on second tri
mester elective terminations would have a net cost of $74 million in Michig
an and $2 billion annually in the United States. (C) 2000 Wiley-Liss, Inc.